Global Acute Respiratory Distress Syndrome Treatment Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	161 Pages	TechNavio	March, 2024	INF18655858

Best Price Guarantee
Price	from $2,500
Length	161 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18655858

Global Acute Respiratory Distress Syndrome Treatment Market 2024-2028

The acute respiratory distress syndrome treatment market is forecasted to grow by USD 1.22 bn during 2023-2028, accelerating at a CAGR of 6.9% during the forecast period. The report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on lung-protective ventilation strategies, advances in precision medicine and biomarker research, and increasing utilization of ecmo therapy.

Technavio's acute respiratory distress syndrome treatment market is segmented as below:

By Distribution Channel

Hospitals pharmacies
Retail pharmacies
Online pharmacies

By Route Of Administration

Oral
Injection
Inhalation

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing interest in immunomodulatory therapies for ards as one of the prime reasons driving the acute respiratory distress syndrome treatment market growth during the next few years. Also, emergence of ards drug repurposing strategies and increasing recognition of multimodal supportive care for ards will lead to sizable demand in the market.

The report on the acute respiratory distress syndrome treatment market covers the following areas:

Acute respiratory distress syndrome treatment market sizing
Acute respiratory distress syndrome treatment market forecast
Acute respiratory distress syndrome treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute respiratory distress syndrome treatment market vendors that include Air Liquide SA, Athersys Inc., Boston Scientific Corporation, Dragerwerk AG and Co. KGaA, Getinge AB, Koninklijke Philips N.V., LivaNova PLC, Medtronic, Nihon Kohden Corp., SCHILLER AG, Sleepnet Corp., Stryker Corp., Vyaire Medical Inc., Smiths Group Plc, ResMed Inc., Hamilton Medical AG, GE Healthcare Technologies Inc., Fisher and Paykel Healthcare Corp. Ltd., Edesa Biotech Inc., and APEPTICO Forschung und Entwicklung GmbH. Also, the acute respiratory distress syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global acute respiratory distress syndrome treatment market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global acute respiratory distress syndrome treatment market 2018 - 2022 ($ billion); 4.2 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Route of Administration Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Exhibit 32: Chart on Comparison by Distribution Channel; Exhibit 33: Data Table on Comparison by Distribution Channel; 6.3 Hospitals pharmacies - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Hospitals pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospitals pharmacies - Year-over-year growth 2023-2028 (%); 6.4 Retail pharmacies - Market size and forecast 2023-2028; Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); 6.5 Online pharmacies - Market size and forecast 2023-2028; Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Distribution Channel; Exhibit 46: Market opportunity by Distribution Channel ($ billion); Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Route of Administration: 7.1 Market segments; Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%); Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%); 7.2 Comparison by Route of Administration; Exhibit 50: Chart on Comparison by Route of Administration; Exhibit 51: Data Table on Comparison by Route of Administration; 7.3 Oral - Market size and forecast 2023-2028; Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%); 7.4 Injection - Market size and forecast 2023-2028; Exhibit 56: Chart on Injection - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on Injection - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on Injection - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Injection - Year-over-year growth 2023-2028 (%); 7.5 Inhalation - Market size and forecast 2023-2028; Exhibit 60: Chart on Inhalation - Market size and forecast 2023-2028 ($ billion); Exhibit 61: Data Table on Inhalation - Market size and forecast 2023-2028 ($ billion); Exhibit 62: Chart on Inhalation - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Inhalation - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Route of Administration; Exhibit 64: Market opportunity by Route of Administration ($ billion); Exhibit 65: Data Table on Market opportunity by Route of Administration ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 France - Market size and forecast 2023-2028; Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ billion); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 APEPTICO Forschung und Entwicklung GmbH; Exhibit 115: APEPTICO Forschung und Entwicklung GmbH - Overview; Exhibit 116: APEPTICO Forschung und Entwicklung GmbH - Product / Service; Exhibit 117: APEPTICO Forschung und Entwicklung GmbH - Key offerings; 12.4 Athersys Inc.; Exhibit 118: Athersys Inc. - Overview; Exhibit 119: Athersys Inc. - Product / Service; Exhibit 120: Athersys Inc. - Key offerings; 12.5 Dragerwerk AG and Co. KGaA; Exhibit 121: Dragerwerk AG and Co. KGaA - Overview; Exhibit 122: Dragerwerk AG and Co. KGaA - Business segments; Exhibit 123: Dragerwerk AG and Co. KGaA - Key offerings; Exhibit 124: Dragerwerk AG and Co. KGaA - Segment focus; 12.6 Edesa Biotech Inc.; Exhibit 125: Edesa Biotech Inc. - Overview; Exhibit 126: Edesa Biotech Inc. - Product / Service; Exhibit 127: Edesa Biotech Inc. - Key offerings; 12.7 Fisher and Paykel Healthcare Corp. Ltd.; Exhibit 128: Fisher and Paykel Healthcare Corp. Ltd. - Overview; Exhibit 129: Fisher and Paykel Healthcare Corp. Ltd. - Product / Service; Exhibit 130: Fisher and Paykel Healthcare Corp. Ltd. - Key news; Exhibit 131: Fisher and Paykel Healthcare Corp. Ltd. - Key offerings; 12.8 GE Healthcare Technologies Inc.; Exhibit 132: GE Healthcare Technologies Inc. - Overview; Exhibit 133: GE Healthcare Technologies Inc. - Business segments; Exhibit 134: GE Healthcare Technologies Inc. - Key news; Exhibit 135: GE Healthcare Technologies Inc. - Key offerings; Exhibit 136: GE Healthcare Technologies Inc. - Segment focus; 12.9 Getinge AB; Exhibit 137: Getinge AB - Overview; Exhibit 138: Getinge AB - Business segments; Exhibit 139: Getinge AB - Key news; Exhibit 140: Getinge AB - Key offerings; Exhibit 141: Getinge AB - Segment focus; 12.10 Hamilton Medical AG; Exhibit 142: Hamilton Medical AG - Overview; Exhibit 143: Hamilton Medical AG - Product / Service; Exhibit 144: Hamilton Medical AG - Key offerings; 12.11 Koninklijke Philips N.V.; Exhibit 145: Koninklijke Philips N.V. - Overview; Exhibit 146: Koninklijke Philips N.V. - Business segments; Exhibit 147: Koninklijke Philips N.V. - Key news; Exhibit 148: Koninklijke Philips N.V. - Key offerings; Exhibit 149: Koninklijke Philips N.V. - Segment focus; 12.12 LivaNova PLC; Exhibit 150: LivaNova PLC - Overview; Exhibit 151: LivaNova PLC - Business segments; Exhibit 152: LivaNova PLC - Key news; Exhibit 153: LivaNova PLC - Key offerings; Exhibit 154: LivaNova PLC - Segment focus; 12.13 Medtronic; Exhibit 155: Medtronic - Overview; Exhibit 156: Medtronic - Business segments; Exhibit 157: Medtronic - Key news; Exhibit 158: Medtronic - Key offerings; Exhibit 159: Medtronic - Segment focus; 12.14 Nihon Kohden Corp.; Exhibit 160: Nihon Kohden Corp. - Overview; Exhibit 161: Nihon Kohden Corp. - Product / Service; Exhibit 162: Nihon Kohden Corp. - Key offerings; 12.15 ResMed Inc.; Exhibit 163: ResMed Inc. - Overview; Exhibit 164: ResMed Inc. - Business segments; Exhibit 165: ResMed Inc. - Key news; Exhibit 166: ResMed Inc. - Key offerings; Exhibit 167: ResMed Inc. - Segment focus; 12.16 Smiths Group Plc; Exhibit 168: Smiths Group Plc - Overview; Exhibit 169: Smiths Group Plc - Business segments; Exhibit 170: Smiths Group Plc - Key news; Exhibit 171: Smiths Group Plc - Key offerings; Exhibit 172: Smiths Group Plc - Segment focus; 12.17 Vyaire Medical Inc.; Exhibit 173: Vyaire Medical Inc. - Overview; Exhibit 174: Vyaire Medical Inc. - Product / Service; Exhibit 175: Vyaire Medical Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 176: Inclusions checklist; Exhibit 177: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 178: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 179: Research methodology; Exhibit 180: Validation techniques employed for market sizing; Exhibit 181: Information sources; 13.5 List of abbreviations; Exhibit 182: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global acute respiratory distress syndrome treatment market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Distribution Channel; Exhibits33: Data Table on Comparison by Distribution Channel; Exhibits34: Chart on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Hospitals pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Hospitals pharmacies - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospitals pharmacies - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Distribution Channel ($ billion); Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits48: Chart on Route of Administration - Market share 2023-2028 (%); Exhibits49: Data Table on Route of Administration - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Route of Administration; Exhibits51: Data Table on Comparison by Route of Administration; Exhibits52: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Injection - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on Injection - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on Injection - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Injection - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Inhalation - Market size and forecast 2023-2028 ($ billion); Exhibits61: Data Table on Inhalation - Market size and forecast 2023-2028 ($ billion); Exhibits62: Chart on Inhalation - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Inhalation - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by Route of Administration ($ billion); Exhibits65: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ billion); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: APEPTICO Forschung und Entwicklung GmbH - Overview; Exhibits116: APEPTICO Forschung und Entwicklung GmbH - Product / Service; Exhibits117: APEPTICO Forschung und Entwicklung GmbH - Key offerings; Exhibits118: Athersys Inc. - Overview; Exhibits119: Athersys Inc. - Product / Service; Exhibits120: Athersys Inc. - Key offerings; Exhibits121: Dragerwerk AG and Co. KGaA - Overview; Exhibits122: Dragerwerk AG and Co. KGaA - Business segments; Exhibits123: Dragerwerk AG and Co. KGaA - Key offerings; Exhibits124: Dragerwerk AG and Co. KGaA - Segment focus; Exhibits125: Edesa Biotech Inc. - Overview; Exhibits126: Edesa Biotech Inc. - Product / Service; Exhibits127: Edesa Biotech Inc. - Key offerings; Exhibits128: Fisher and Paykel Healthcare Corp. Ltd. - Overview; Exhibits129: Fisher and Paykel Healthcare Corp. Ltd. - Product / Service; Exhibits130: Fisher and Paykel Healthcare Corp. Ltd. - Key news; Exhibits131: Fisher and Paykel Healthcare Corp. Ltd. - Key offerings; Exhibits132: GE Healthcare Technologies Inc. - Overview; Exhibits133: GE Healthcare Technologies Inc. - Business segments; Exhibits134: GE Healthcare Technologies Inc. - Key news; Exhibits135: GE Healthcare Technologies Inc. - Key offerings; Exhibits136: GE Healthcare Technologies Inc. - Segment focus; Exhibits137: Getinge AB - Overview; Exhibits138: Getinge AB - Business segments; Exhibits139: Getinge AB - Key news; Exhibits140: Getinge AB - Key offerings; Exhibits141: Getinge AB - Segment focus; Exhibits142: Hamilton Medical AG - Overview; Exhibits143: Hamilton Medical AG - Product / Service; Exhibits144: Hamilton Medical AG - Key offerings; Exhibits145: Koninklijke Philips N.V. - Overview; Exhibits146: Koninklijke Philips N.V. - Business segments; Exhibits147: Koninklijke Philips N.V. - Key news; Exhibits148: Koninklijke Philips N.V. - Key offerings; Exhibits149: Koninklijke Philips N.V. - Segment focus; Exhibits150: LivaNova PLC - Overview; Exhibits151: LivaNova PLC - Business segments; Exhibits152: LivaNova PLC - Key news; Exhibits153: LivaNova PLC - Key offerings; Exhibits154: LivaNova PLC - Segment focus; Exhibits155: Medtronic - Overview; Exhibits156: Medtronic - Business segments; Exhibits157: Medtronic - Key news; Exhibits158: Medtronic - Key offerings; Exhibits159: Medtronic - Segment focus; Exhibits160: Nihon Kohden Corp. - Overview; Exhibits161: Nihon Kohden Corp. - Product / Service; Exhibits162: Nihon Kohden Corp. - Key offerings; Exhibits163: ResMed Inc. - Overview; Exhibits164: ResMed Inc. - Business segments; Exhibits165: ResMed Inc. - Key news; Exhibits166: ResMed Inc. - Key offerings; Exhibits167: ResMed Inc. - Segment focus; Exhibits168: Smiths Group Plc - Overview; Exhibits169: Smiths Group Plc - Business segments; Exhibits170: Smiths Group Plc - Key news; Exhibits171: Smiths Group Plc - Key offerings; Exhibits172: Smiths Group Plc - Segment focus; Exhibits173: Vyaire Medical Inc. - Overview; Exhibits174: Vyaire Medical Inc. - Product / Service; Exhibits175: Vyaire Medical Inc. - Key offerings; Exhibits176: Inclusions checklist; Exhibits177: Exclusions checklist; Exhibits178: Currency conversion rates for US$; Exhibits179: Research methodology; Exhibits180: Validation techniques employed for market sizing; Exhibits181: Information sources; Exhibits182: List of abbreviations